Onconetix Inc (NASDAQ: ONCO)’s stock price has plunge by -3.97relation to previous closing price of 0.13. Nevertheless, the company has seen a -32.02% plunge in its stock price over the last five trading sessions. accessnewswire.com reported 2025-02-27 that VANCOUVER, BC / ACCESS Newswire / February 27, 2025 / Onco-Innovations Limited (CSE:ONCO)(OTCQB:ONNVF)(Frankfurt:W1H,WKN: A3EKSZ) (“Onco” or the “Company”) is pleased to provide information regarding its wholly-owned subsidiary, Inka Health (“Inka”), which has made significant strides in advancing AI-driven oncology research by leading a transformative study protocol1 published in medRxiv in September 2024, focused on AI-generated synthetic patient models. This innovative research aims to advance the study of oncology by creating synthetic patient data, thereby leveraging advanced machine learning techniques to overcome critical challenges, particularly in the study of rare cancers where traditional patient data is often unavailable or difficult to obtain.
Is It Worth Investing in Onconetix Inc (NASDAQ: ONCO) Right Now?
Company’s 36-month beta value is 3.38.Analysts have differing opinions on the stock, with 0 analysts rating it as a “buy,” 0 as “overweight,” 1 as “hold,” and 0 as “sell.”
The public float for ONCO is 9.39M, and currently, short sellers hold a 2.23% ratio of that floaft. The average trading volume of ONCO on March 18, 2025 was 9.99M shares.
ONCO’s Market Performance
ONCO stock saw a decrease of -32.02% in the past week, with a monthly decline of -77.60% and a quarterly a decrease of -74.09%. The volatility ratio for the week is 15.22%, and the volatility levels for the last 30 days are 12.21% for Onconetix Inc (ONCO). The simple moving average for the past 20 days is -52.60% for ONCO’s stock, with a -96.44% simple moving average for the past 200 days.
ONCO Trading at -73.21% from the 50-Day Moving Average
After a stumble in the market that brought ONCO to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -99.43% of loss for the given period.
Volatility was left at 12.21%, however, over the last 30 days, the volatility rate increased by 15.22%, as shares sank -75.62% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -81.28% lower at present.
During the last 5 trading sessions, ONCO fell by -31.52%, which changed the moving average for the period of 200-days by -98.97% in comparison to the 20-day moving average, which settled at $0.2553. In addition, Onconetix Inc saw -80.79% in overturn over a single year, with a tendency to cut further losses.
Stock Fundamentals for ONCO
Current profitability levels for the company are sitting at:
- -13.5 for the present operating margin
- -0.41 for the gross margin
The net margin for Onconetix Inc stands at -27.59. The total capital return value is set at -0.57. Equity return is now at value -233.77, with -114.93 for asset returns.
Based on Onconetix Inc (ONCO), the company’s capital structure generated 0.23 points at debt to capital in total, while cash flow to debt ratio is standing at -1.39. The debt to equity ratio resting at 0.29. The interest coverage ratio of the stock is -18.73.
Currently, EBITDA for the company is -36.71 million with net debt to EBITDA at -0.19. When we switch over and look at the enterprise to sales, we see a ratio of 6.09. The receivables turnover for the company is 19.08for trailing twelve months and the total asset turnover is 0.03. The liquidity ratio also appears to be rather interesting for investors as it stands at 0.06.
Conclusion
In a nutshell, Onconetix Inc (ONCO) has experienced a bad performance in recent times. The stock has received mixed “buy” and “hold” ratings from analysts. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
